CAMP - Childhood Asthma Management Program

Hankinson's
spirometric
calculator

 The Childhood Asthma Management Program (CAMP) was a 5 year randomized, placebo-controlled trial of the safety and efficacy of two inhaled anti-inflammatory therapies for children with mild to moderate asthma.

  The CAMP Continuation Study (CAMPCS) was a 4.5 year observational follow-up study of the children enrolled in the Childhood Asthma Management Program to complete the assessment of the effects of long term treatment early in childhood on asthma outcomes and physical growth and development.

  The CAMP Continuation Study/Phase 2 (CAMPCS/2) extends the observational follow-up of the CAMP participants for an additional 3.5 years to investigate the natural history of asthma into young adulthood.

  The CAMP Continuation Study/Phase 3 (CAMPCS/3) extends the observational follow-up of the CAMP participants for an additional 3.5 years to study the determinants of lung growth and progression of obstruction due to persistent childhood asthma.

 

 

 

 

 

 


 

17576

    Last updated:  08 August 2011
    ?2007, CAMPCS/3, JHU, Department of Epidemiology,  All Rights Reserved